{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:35:56Z","timestamp":1791894956487,"version":"4.3.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1038\/nm1067","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T14:13:27Z","timestamp":1090505607000},"page":"S2-S9","source":"Crossref","is-referenced-by-count":588,"title":["Molecular pathways to neurodegeneration"],"prefix":"10.1038","volume":"10","author":[{"given":"Ella","family":"Bossy-Wetzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schwarzenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"BFnm1067_CR1","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02264","volume":"426","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D.J. Folding proteins in fatal ways. Nature 426, 900\u2013904 (2003).","journal-title":"Nature"},{"key":"BFnm1067_CR2","first-page":"265","volume":"4","author":"AD Roses","year":"1996","unstructured":"Roses, A.D. Alipoprotein E in neurology. Curr. Opin. Neurol. 4, 265\u2013270 (1996).","journal-title":"Curr. Opin."},{"key":"BFnm1067_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","volume":"20","author":"J Hardy","year":"1997","unstructured":"Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154\u2013159 (1997).","journal-title":"Trends Neurosci."},{"key":"BFnm1067_CR4","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1038\/399a023","volume":"399","author":"DJ Selkoe","year":"1999","unstructured":"Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23\u2013A31 (1999).","journal-title":"Nature"},{"key":"BFnm1067_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00019052-200008000-00002","volume":"13","author":"A Delacourte","year":"2000","unstructured":"Delacourte, A. & Buee, L. Tau pathology: a marker of neurodegenerative disorders. Curr. Opin. Neurol. 13, 371\u2013376 (2000).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnm1067_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/7562","volume":"6","author":"J Rossjohn","year":"1999","unstructured":"Rossjohn, J. et al. Crystal structure of the N-terminal, growth factor\u2013like domain of Alzheimer amyloid precursor protein. Nat. Struct. Biol. 6, 327\u2013331 (1999).","journal-title":"Nat. Struct. Biol."},{"key":"BFnm1067_CR7","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1074\/jbc.M300629200","volume":"278","author":"KJ Barnham","year":"2003","unstructured":"Barnham, K.J. et al. Structure of the Alzheimer's disease amyloid precursor binding protein. A regulator of neuronal copper homeostasis. J. Biol. Chem. 278, 17401\u201317407 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR8","doi-asserted-by":"publisher","first-page":"12700","DOI":"10.1021\/bi9810757","volume":"37","author":"AA Watson","year":"1998","unstructured":"Watson, A.A., Fairlie, D.P. & Craik, D.J. Solution structure of methionine-oxidized amyloid \u03b2-peptide (1\u201340). Does oxidation affect conformational switching? Biochemistry 37, 12700\u201312706 (1998).","journal-title":"Biochemistry"},{"key":"BFnm1067_CR9","doi-asserted-by":"publisher","first-page":"20466","DOI":"10.1074\/jbc.M100175200","volume":"276","author":"CC Curtain","year":"2001","unstructured":"Curtain, C.C. et al. Alzheimer's disease amyloid-\u03b2 binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276, 20466\u201320473 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR10","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1093\/hmg\/ddh093","volume":"13","author":"A Singleton","year":"2004","unstructured":"Singleton, A., Myers, A. & Hardy, J. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum. Mol. Genet. 13 (Spec. no. 1), R123\u2013R126 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1067_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0962-8924(02)02394-2","volume":"12","author":"C Haas","year":"2002","unstructured":"Haas, C. & Steiner, H. Alzheimer disease-\u03b3-secretase: a complex story of GxGD-type presenilin proteases. Trends Cell Biol. 12, 556\u2013562 (2002).","journal-title":"Trends Cell Biol."},{"key":"BFnm1067_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncb960","volume":"5","author":"D Edbauer","year":"2003","unstructured":"Edbauer, D. et al. Reconstitution of \u03b3-secretase activity. Nat. Cell Biol. 5, 486\u2013488 (2003).","journal-title":"Nat. Cell Biol."},{"key":"BFnm1067_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"C Haass","year":"2004","unstructured":"Haass, C. Take five-BACE and the \u03b3-secretase quartet conduct Alzheimer's amyloid \u03b2-peptide generation. EMBO J. 23, 483\u2013488 (2004).","journal-title":"EMBO J."},{"key":"BFnm1067_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1042\/bse0330117","volume":"33","author":"M Hutton","year":"1998","unstructured":"Hutton, M., Perez-Tur, J. & Hardy, J. Genetics of Alzheimer's disease. Essays Biochem. 33, 117\u2013131 (1998).","journal-title":"Essays Biochem."},{"key":"BFnm1067_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner, D. et al. Secreted amyloid \u03b2-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864\u2013870 (1996).","journal-title":"Nat. Med."},{"key":"BFnm1067_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt, D.R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939\u2013945 (1997).","journal-title":"Neuron"},{"key":"BFnm1067_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387\u2013390 (1998).","journal-title":"Nature"},{"key":"BFnm1067_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0896-6273(00)80637-6","volume":"21","author":"S Naruse","year":"1998","unstructured":"Naruse, S. et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213\u20131221 (1998).","journal-title":"Neuron"},{"key":"BFnm1067_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/74656","volume":"6","author":"DC Lu","year":"2000","unstructured":"Lu, D.C. et al. A second cytotoxic proteolytic pepide derived from amyloid \u03b2-protein precursor. Nat. Med. 6, 385\u2013386 (2000).","journal-title":"Nat. Med."},{"key":"BFnm1067_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.48.3.626","volume":"48","author":"WF Stewart","year":"1997","unstructured":"Stewart, W.F., Kawas, C., Corrada, M. & Metter, E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626\u2013632 (1997).","journal-title":"Neurology"},{"key":"BFnm1067_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen, S. et al. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature 414, 212\u2013216 (2001).","journal-title":"Nature"},{"key":"BFnm1067_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/428473a","volume":"428","author":"SA Lipton","year":"2004","unstructured":"Lipton, S.A. Concepts: turning down but not off\u2014neuroprotection requires a paradigm shift in drug development. Nature 428, 473 (2004).","journal-title":"Nature"},{"key":"BFnm1067_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0896-6273(00)00124-0","volume":"28","author":"A Kamal","year":"2000","unstructured":"Kamal, A., Stokin, G.B., Yang, Z., Xia, C.H. & Goldstein, L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449\u2013459 (2000).","journal-title":"Neuron"},{"key":"BFnm1067_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/414643a","volume":"414","author":"A Kamal","year":"2001","unstructured":"Kamal, A., Almenar-Queralt, A., LeBlanc, J.F., Roberts, E.A. & Goldstein, L.S. Kinesin-mediated axonal transport of a membrane compartment containing \u03b2-secretase and presenilin-1 requires APP. Nature 414, 643\u2013648 (2001).","journal-title":"Nature"},{"key":"BFnm1067_CR25","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1523\/JNEUROSCI.23-11-04499.2003","volume":"23","author":"G Pigino","year":"2003","unstructured":"Pigino, G. et al. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23, 4499\u20134508 (2003).","journal-title":"J. Neurosci."},{"key":"BFnm1067_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"BFnm1067_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/6374","volume":"2","author":"PF Chapman","year":"1999","unstructured":"Chapman, P.F. et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271\u2013276 (1999).","journal-title":"Nat. Neurosci."},{"key":"BFnm1067_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D.M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"BFnm1067_CR29","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1523\/JNEUROSCI.21-15-05703.2001","volume":"21","author":"A Stephan","year":"2001","unstructured":"Stephan, A., Laroche, S. & Davis, S. Generation of aggregated \u03b2-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21, 5703\u20135714 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm1067_CR30","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1016\/S0021-9258(19)85394-2","volume":"268","author":"AI Bush","year":"1993","unstructured":"Bush, A.I. et al. A novel zinc(II) binding site modulates the function of the \u03b2A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268, 16109\u201316112 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR31","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.8073293","volume":"265","author":"AI Bush","year":"1994","unstructured":"Bush, A.I. et al. Rapid induction of Alzheimer A \u03b2 amyloid formation by zinc. Science 265, 1464\u20131467 (1994).","journal-title":"Science"},{"key":"BFnm1067_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"MA Lovell","year":"1998","unstructured":"Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L. & Markesbery, W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47\u201352 (1998).","journal-title":"J. Neurol. Sci."},{"key":"BFnm1067_CR33","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1021\/bi0272151","volume":"42","author":"J Dong","year":"2003","unstructured":"Dong, J. et al. Metal binding and oxidation of amyloid-\u03b2 within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42, 2768\u20132773 (2003).","journal-title":"Biochemistry"},{"key":"BFnm1067_CR34","doi-asserted-by":"publisher","first-page":"40302","DOI":"10.1074\/jbc.M206428200","volume":"277","author":"C Opazo","year":"2002","unstructured":"Opazo, C. et al. Metalloenzyme-like activity of Alzheimer's disease \u03b2-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2 . J. Biol. Chem. 277, 40302\u201340308 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00002093-200307000-00005","volume":"17","author":"AI Bush","year":"2003","unstructured":"Bush, A.I. Copper, zinc, and the metallobiology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 17, 147\u2013150 (2003).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnm1067_CR36","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1021\/bi990438f","volume":"38","author":"X Huang","year":"1999","unstructured":"Huang, X. et al. The A \u03b2 peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609\u20137616 (1999).","journal-title":"Biochemistry"},{"key":"BFnm1067_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0896-6273(04)00015-7","volume":"41","author":"E Bossy-Wetzel","year":"2004","unstructured":"Bossy-Wetzel, E. et al. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 41, 351\u2013365 (2004).","journal-title":"Neuron"},{"key":"BFnm1067_CR38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0197-4580(02)00120-3","volume":"23","author":"AI Bush","year":"2002","unstructured":"Bush, A.I. Metal complexing agents as therapies for Alzheimer's disease. Neurobiol. Aging 23, 1031\u20131038 (2002).","journal-title":"Neurobiol. Aging"},{"key":"BFnm1067_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny, R.A. et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665\u2013676 (2001).","journal-title":"Neuron"},{"key":"BFnm1067_CR40","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie, C.W. et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A\u03b2 amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685\u20131691 (2003).","journal-title":"Arch. Neurol."},{"key":"BFnm1067_CR41","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai, K. et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21, 3017\u20133023 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm1067_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada, H.K., Biswas, G., Robin, M.A. & Avadhani, N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41\u201354 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnm1067_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/nbdi.2002.0516","volume":"10","author":"CS Casley","year":"2002","unstructured":"Casley, C.S. et al. \u03b2-Amyloid fragment 25\u201335 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10, 258\u2013267 (2002).","journal-title":"Neurobiol. Dis."},{"key":"BFnm1067_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.0022-3042.2001.00681.x","volume":"80","author":"CS Casley","year":"2002","unstructured":"Casley, C.S., Canevari, L., Land, J.M., Clark, J.B. & Sharpe, M.A. \u03b2-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91\u2013100 (2002).","journal-title":"J. Neurochem."},{"key":"BFnm1067_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1091230","volume":"304","author":"JW Lustbader","year":"2004","unstructured":"Lustbader, J.W. et al. ABAD directly links A\u03b2 to mitochondrial toxicity in Alzheimer's disease. Science 304, 448\u2013452 (2004).","journal-title":"Science"},{"key":"BFnm1067_CR46","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu, J. et al. Dopamine-dependent neurotoxicity of \u03b1-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8, 600\u2013606 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1067_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S1474-4422(03)00350-8","volume":"2","author":"J Hardy","year":"2003","unstructured":"Hardy, J., Cookson, M.R. & Singleton, A. Genes and parkinsonism. Lancet Neurol. 2, 221\u2013228 (2003).","journal-title":"Lancet Neurol."},{"key":"BFnm1067_CR48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J.W., Ballard, P., Tetrud, J.W. & Irwin, I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979\u2013980 (1983).","journal-title":"Science"},{"key":"BFnm1067_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston, J.W. et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598\u2013605 (1999).","journal-title":"Ann. Neurol."},{"key":"BFnm1067_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0014-2999(93)90800-W","volume":"230","author":"S Rose","year":"1993","unstructured":"Rose, S. et al. Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. Eur. J. Pharmacol. 230, 177\u2013185 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnm1067_CR51","first-page":"197","volume":"60","author":"I Irwin","year":"1993","unstructured":"Irwin, I., DeLanney, L.E. & Langston, J.W. MPTP and aging. Studies in the C57BL\/6 mouse. Adv. Neurol. 60, 197\u2013206 (1993).","journal-title":"Adv. Neurol."},{"key":"BFnm1067_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0197-4580(95)02012-8","volume":"16","author":"A Ovadia","year":"1995","unstructured":"Ovadia, A., Zhang, Z. & Gash, D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol. Aging 16, 931\u2013937 (1995).","journal-title":"Neurobiol. Aging"},{"key":"BFnm1067_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur, D. et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899\u2013909 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR54","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301\u20131306 (2000).","journal-title":"Nat. Neurosci."},{"key":"BFnm1067_CR55","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M.H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"BFnm1067_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605\u2013608 (1998).","journal-title":"Nature"},{"key":"BFnm1067_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256\u2013259 (2003).","journal-title":"Science"},{"key":"BFnm1067_CR58","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E.M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158\u20131160 (2004)","journal-title":"Science"},{"key":"BFnm1067_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0896-6273(03)00684-6","volume":"40","author":"JL Eriksen","year":"2003","unstructured":"Eriksen, J.L., Dawson, T.M., Dickson, D.W. & Petrucelli, L. Caught in the act. \u03b1-Synuclein is the culprit in Parkinson's disease. Neuron 40, 453\u2013456 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1073858403260392","volume":"10","author":"MJ Baptista","year":"2004","unstructured":"Baptista, M.J., Cookson, M.R. & Miller, D.W. Parkin and \u03b1-synuclein: opponent actions in the pathogenesis of Parkinson's disease. Neuroscientist 10, 63\u201372 (2004).","journal-title":"Neuroscientist"},{"key":"BFnm1067_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/sj.embor.embor764","volume":"4","author":"E Sakata","year":"2003","unstructured":"Sakata, E. et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301\u2013306 (2003).","journal-title":"EMBO Rep."},{"key":"BFnm1067_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/NMM:3:1:1","volume":"3","author":"MR Cookson","year":"2003","unstructured":"Cookson, M.R. Parkin's substrates and the pathways leading to neuronal damage. Neuromolecular Med. 3, 1\u201313 (2003).","journal-title":"Neuromolecular Med."},{"key":"BFnm1067_CR63","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/hmg\/ddg328","volume":"12","author":"MR Cookson","year":"2003","unstructured":"Cookson, M.R. et al. RING finger 1 mutations in Parkin produce altered localization of the protein. Hum. Mol. Genet. 12, 2957\u20132965 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1067_CR64","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","volume":"105","author":"Y Imai","year":"2001","unstructured":"Imai, Y. et al. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891\u2013902 (2001).","journal-title":"Cell"},{"key":"BFnm1067_CR65","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","volume":"36","author":"L Petrucelli","year":"2002","unstructured":"Petrucelli, L. et al. Parkin protects against the toxicity associated with mutant \u03b1-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36, 1007\u20131019 (2002).","journal-title":"Neuron"},{"key":"BFnm1067_CR66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0896-6273(03)00084-9","volume":"37","author":"JF Staropoli","year":"2003","unstructured":"Staropoli, J.F. et al. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735\u2013749 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/hmg\/ddg044","volume":"12","author":"F Darios","year":"2003","unstructured":"Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517\u2013526 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1067_CR68","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0896-6273(03)00143-0","volume":"37","author":"Y Yang","year":"2003","unstructured":"Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. & Lu, B. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37, 911\u2013924 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR69","doi-asserted-by":"publisher","first-page":"22044","DOI":"10.1074\/jbc.M212235200","volume":"278","author":"YC Tsai","year":"2003","unstructured":"Tsai, Y.C., Fishman, P.S., Thakor, N.V. & Oyler, G.A. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. 278, 22044\u201322055 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR70","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene, J.C. et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100, 4078\u20134083 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR71","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino, J.J. et al. Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice. J. Biol. Chem. 279, 18614\u201318622 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR72","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1126\/science.1093891","volume":"304","author":"KK Chung","year":"2004","unstructured":"Chung, K.K. et al. S-Nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328\u20131331 (2004)","journal-title":"Science"},{"key":"BFnm1067_CR73","doi-asserted-by":"crossref","unstructured":"Yao, D., et al. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ligase activity. Proc. Natl. Acad. Sci. USA (2004), in press.","DOI":"10.1073\/pnas.0404161101"},{"key":"BFnm1067_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0896-6273(02)01166-2","volume":"37","author":"MR Cookson","year":"2003","unstructured":"Cookson, M.R. Pathways to parkinsonism. Neuron 37, 7\u201310 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.embor.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira, T. et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5, 213\u2013218 (2004).","journal-title":"EMBO Rep."},{"key":"BFnm1067_CR76","doi-asserted-by":"publisher","first-page":"31380","DOI":"10.1074\/jbc.M305878200","volume":"278","author":"K Honbou","year":"2003","unstructured":"Honbou, K. et al. The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J. Biol. Chem. 278, 31380\u201331384 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR77","doi-asserted-by":"publisher","first-page":"9256","DOI":"10.1073\/pnas.1133288100","volume":"100","author":"MA Wilson","year":"2003","unstructured":"Wilson, M.A., Collins, J.L., Hod, Y., Ringe, D. & Petsko, G.A. The 1.1-\u00c5 resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early-onset Parkinson's disease. Proc. Natl. Acad. Sci. USA 100, 9256\u20139261 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR78","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier, Y. et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403\u2013406 (1995).","journal-title":"Nature"},{"key":"BFnm1067_CR79","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075\u20131081 (1995).","journal-title":"Neuron"},{"key":"BFnm1067_CR80","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov, A.V. et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731\u2013736 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnm1067_CR81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1172\/JCI17742","volume":"111","author":"AB Young","year":"2003","unstructured":"Young, A.B. Huntingtin in health and disease. J. Clin. Invest. 111, 299\u2013302 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnm1067_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes, P. & Wanker, E.E. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28, 425\u2013433 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"BFnm1067_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1073\/pnas.0305145101","volume":"101","author":"H Li","year":"2004","unstructured":"Li, H., Gu, X., Dawson, V.L. & Dawson, T.M. Identification of calcium- and nitric oxide\u2013regulated genes by differential analysis of library expression (DAzLE). Proc. Natl. Acad. Sci. USA 101, 647\u2013652 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR84","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ng1095-115","volume":"11","author":"MA Andrade","year":"1995","unstructured":"Andrade, M.A. & Bork, P. HEAT repeats in the Huntington's disease protein. Nat. Genet. 11, 115\u2013116 (1995).","journal-title":"Nat. Genet."},{"key":"BFnm1067_CR85","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1097-2765(00)80142-2","volume":"2","author":"A Sittler","year":"1998","unstructured":"Sittler, A. et al. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell 2, 427\u2013436 (1998).","journal-title":"Mol. Cell"},{"key":"BFnm1067_CR86","doi-asserted-by":"publisher","first-page":"24713","DOI":"10.1074\/jbc.M103501200","volume":"276","author":"Y Sun","year":"2001","unstructured":"Sun, Y., Savanenin, A., Reddy, P.H. & Liu, Y.F. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95. J. Biol. Chem. 276, 24713\u201324718 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR87","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/hmg\/6.3.487","volume":"6","author":"EE Wanker","year":"1997","unstructured":"Wanker, E.E. et al. HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487\u2013495 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1067_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ng0597-44","volume":"16","author":"MA Kalchman","year":"1997","unstructured":"Kalchman, M.A. et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet. 16, 44\u201353 (1997).","journal-title":"Nat. Genet."},{"key":"BFnm1067_CR89","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/378398a0","volume":"378","author":"XJ Li","year":"1995","unstructured":"Li, X.J. et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398\u2013402 (1995).","journal-title":"Nature"},{"key":"BFnm1067_CR90","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1093\/hmg\/11.23.2815","volume":"11","author":"RR Singaraja","year":"2002","unstructured":"Singaraja, R.R. et al. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 11, 2815\u20132828 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1067_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0896-6273(03)00600-7","volume":"40","author":"MB Feany","year":"2003","unstructured":"Feany, M.B. & La Spada, A.R. Polyglutamines stop traffic: axonal transport as a common target in neurodegenerative diseases. Neuron 40, 1\u20132 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR92","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","volume":"21","author":"H Li","year":"2001","unstructured":"Li, H., Li, S.H., Yu, Z.X., Shelbourne, P. & Li, X.J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21, 8473\u20138481 (2001).","journal-title":"J. Neurosci."},{"key":"BFnm1067_CR93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0896-6273(03)00594-4","volume":"40","author":"S Gunawardena","year":"2003","unstructured":"Gunawardena, S. et al. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40, 25\u201340 (2003).","journal-title":"Neuron"},{"key":"BFnm1067_CR94","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan, J.S. et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739\u2013743 (2001).","journal-title":"Nature"},{"key":"BFnm1067_CR95","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah, A.W. et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238\u20132243 (2002).","journal-title":"Science"},{"key":"BFnm1067_CR96","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","volume":"24","author":"K Obrietan","year":"2004","unstructured":"Obrietan, K. & Hoyt, K.R. CRE-mediated transcription is increased in Huntington's disease transgenic mice. J. Neurosci. 24, 791\u2013796 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm1067_CR97","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1074\/jbc.M310226200","volume":"279","author":"KL Sugars","year":"2004","unstructured":"Sugars, K.L., Brown, R., Cook, L.J., Swartz, J. & Rubinsztein, D.C. Decreased cAMP response element\u2013mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J. Biol. Chem. 279, 4988\u20134999 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm1067_CR98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1385\/MN:23:1:21","volume":"23","author":"S Sipione","year":"2001","unstructured":"Sipione, S. & Cattaneo, E. Modeling Huntington's disease in cells, flies, and mice. Mol. Neurobiol. 23, 21\u201351 (2001).","journal-title":"Mol. Neurobiol."},{"key":"BFnm1067_CR99","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein, D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18, 202\u2013209 (2002).","journal-title":"Trends Genet."},{"key":"BFnm1067_CR100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D.R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"BFnm1067_CR101","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1073\/pnas.0305143101","volume":"101","author":"MA Hough","year":"2004","unstructured":"Hough, M.A. et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. USA 101, 5976\u20135981 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR102","doi-asserted-by":"publisher","first-page":"9989","DOI":"10.1073\/pnas.96.18.9989","volume":"96","author":"EH Koo","year":"1999","unstructured":"Koo, E.H., Lansbury, P.T., Jr. & Kelly, J.W. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. USA 96, 9989\u20139990 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR103","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1073\/pnas.0401934101","volume":"101","author":"SS Ray","year":"2004","unstructured":"Ray, S.S. & Lansbury, P.T., Jr. A possible therapeutic target for Lou Gehrig's disease. Proc. Natl. Acad. Sci. USA 101, 5701\u20135702 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1067_CR104","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement, A.M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113\u2013117 (2003).","journal-title":"Science"},{"key":"BFnm1067_CR105","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/427801a","volume":"427","author":"Y Kawahara","year":"2004","unstructured":"Kawahara, Y. et al. Glutamate receptors: RNA editing and death of motor neurons. Nature 427, 801 (2004).","journal-title":"Nature"},{"key":"BFnm1067_CR106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nm0404-347","volume":"10","author":"SA Lipton","year":"2004","unstructured":"Lipton, S.A. Sporadic ALS: blame it on the editor. Nat. Med. 10, 347 (2004).","journal-title":"Nat. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1067","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:02:34Z","timestamp":1684447354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":106,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BFnm1067"],"URL":"https:\/\/doi.org\/10.1038\/nm1067","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}